Pages that link to "Q39896091"

The following pages link to PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription (Q39896091):

Displaying 38 items.

• Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet? (Q26748581) (← links)
• Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer (Q31154012) (← links)
• MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma (Q34182679) (← links)
• Transcriptional inhibition of intestinal NHE8 expression by glucocorticoids involves Pax5 (Q34212100) (← links)
• Retracted: Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3 (Q34949789) (← links)
• The role of the c-Met pathway in lung cancer and the potential for targeted therapy (Q35146937) (← links)
• Diagnostic utility of PAX2 and PAX5 in distinguishing non-small cell lung cancer from small cell lung cancer (Q36464585) (← links)
• MET as a possible target for non-small-cell lung cancer (Q36660673) (← links)
• Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression (Q36797506) (← links)
• Upregulation of Human ST8Sia VI (α2,8-Sialyltransferase) Gene Expression by Physcion in SK-N-BE(2)-C Human Neuroblastoma Cells (Q37209960) (← links)
• PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma (Q37252398) (← links)
• Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors (Q37539304) (← links)
• The function, proteolytic processing, and histopathology of Met in cancer (Q37621003) (← links)
• Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes (Q37707044) (← links)
• PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms (Q37775841) (← links)
• The molecular pathogenesis and management of bronchial carcinoids (Q37833109) (← links)
• Differential expression of RON in small and non-small cell lung cancers (Q38403475) (← links)
• PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells. (Q38846778) (← links)
• Flow cytometric analysis of CD200 expression by pulmonary small cell carcinoma (Q38941113) (← links)
• Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia (Q39101593) (← links)
• Insertion of a nuclear factor kappa B DNA nuclear-targeting sequence potentiates suicide gene therapy efficacy in lung cancer cell lines (Q39296297) (← links)
• Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients. (Q39439183) (← links)
• Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung (Q42651022) (← links)
• C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype (Q46591244) (← links)
• PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma (Q48368856) (← links)
• [Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer]. (Q53232399) (← links)
• [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?]. (Q53512514) (← links)
• The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications. (Q53682879) (← links)
• Modeling small cell lung cancer (SCLC) biology through deterministic and stochastic mathematical models. (Q55110585) (← links)
• Polymorphism in lncRNA AC016683.6 and its interaction with smoking exposure on the susceptibility of lung cancer. (Q55621188) (← links)
• Deacetylase activity-independent transcriptional activation by HDAC2 during TPA-induced HL-60 cell differentiation (Q58708831) (← links)
• Managing Patients With Relapsed Small-Cell Lung Cancer. (Q64910923) (← links)
• Clinical significance of serum hepatocyte growth factor and epidermal growth factor gene somatic mutations in patients with non-squamous non-small cell lung cancer receiving gefitinib or erlotinib (Q84584265) (← links)
• [Neuroendocrine tumors of the lungs. From small cell lung carcinoma to diffuse idiopathic pulmonary neuroendocrine cell hyperplasia] (Q85901880) (← links)
• B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies (Q88090511) (← links)
• Upregulation of CD20 Positive B-Cells and B-Cell Aggregates in the Tumor Infiltration Zone is Associated with Better Survival of Patients with Pancreatic Ductal Adenocarcinoma (Q90162078) (← links)
• JAK3 Variant, Immune Signatures, DNA Methylation, and Social Determinants Linked to Survival Racial Disparities in Head and Neck Cancer Patients (Q91689074) (← links)
• Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA) (Q92255554) (← links)